Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in nongermline BRCA pathogenic variant triplenegative breast cancer
Favorite
Share
More Options
20

Open in WPS to view all 20 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
